Rachel King - Jun 26, 2025 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Alan Musso, as attorney-in-fact for Rachel King
Stock symbol
FULC
Transactions as of
Jun 26, 2025
Transactions value $
$0
Form type
4
Date filed
6/30/2025, 04:15 PM
Previous filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
King Rachel K. Director C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE /s/ Alan Musso, as attorney-in-fact for Rachel King 2025-06-30 0001589712

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +36K $0.00 36K Jun 26, 2025 Common Stock 36K $7.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 26, 2025 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.